F2,6BP, in turn, allosterically activates the rate-limiting enzyme of 6-phosphofructo-1-kinase (PFK-1) in glycolysis process and its synthesis is reported to be highly stimulated in HCC by certain oncogenic alterations which presumably augment glucose consumption rate [27]. The gene discussed is PFKM; the disease is hepatocellular carcinoma.